AMGEN INC (AMGN) Deferred Federal Income Tax Expense (Benefit) USD 2010 - 2023
Historical data
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Amgen Inc annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Amgen Inc annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$1.12 B, a 5.15% increase from 2022.
- Amgen Inc annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$1.19 B, a 285% decline from 2021.
- Amgen Inc annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$308 M, a 4.05% increase from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual Data (USD)